“Cannabinoid receptor (CBR) agonist could act as a protective agent against seizure susceptibility in animal models of epilepsy.

Studies have shown that potassium channels could play a key role in ameliorating neuronal excitability.

In this study, we attempted to evaluate how CBRs and Adenosine Tri-Phosphate (ATP)-sensitive potassium channels collaborate to affect seizure susceptibility by changing the clonic seizure threshold (CST).

In conclusion, CB1 agonist accomplishes at least a part of its anticonvulsant actions through ATP-sensitive potassium channels, probably by decreasing the mitochondrial ATP level to open the potassium channel to induce its anticonvulsant effect.”

https://www.ncbi.nlm.nih.gov/pubmed/30776677

https://linkinghub.elsevier.com/retrieve/pii/S1525505018308503